Literature DB >> 18173235

Mitochondrial dysfunction, oxidative stress, and apoptosis revealed by proteomic and transcriptomic analyses of the striata in two mouse models of Parkinson's disease.

Mark H Chin1, Wei-Jun Qian, Haixing Wang, Vladislav A Petyuk, Joshua S Bloom, Daniel M Sforza, Goran Laćan, Dahai Liu, Arshad H Khan, Rita M Cantor, Diana J Bigelow, William P Melega, David G Camp, Richard D Smith, Desmond J Smith.   

Abstract

The molecular mechanisms underlying the changes in the nigrostriatal pathway in Parkinson's disease (PD) are not completely understood. Here, we use mass spectrometry and microarrays to study the proteomic and transcriptomic changes in the striatum of two mouse models of PD, induced by the distinct neurotoxins 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and methamphetamine (METH). Proteomic analyses resulted in the identification and relative quantification of 912 proteins with two or more unique peptides and 86 proteins with significant abundance changes following neurotoxin treatment. Similarly, microarray analyses revealed 181 genes with significant changes in mRNA, following neurotoxin treatment. The combined protein and gene list provides a clearer picture of the potential mechanisms underlying neurodegeneration observed in PD. Functional analysis of this combined list revealed a number of significant categories, including mitochondrial dysfunction, oxidative stress response, and apoptosis. These results constitute one of the largest descriptive data sets integrating protein and transcript changes for these neurotoxin models with many similar end point phenotypes but distinct mechanisms.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18173235      PMCID: PMC3319057          DOI: 10.1021/pr070546l

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  53 in total

Review 1.  The MEK/ERK cascade: from signaling specificity to diverse functions.

Authors:  Yoav D Shaul; Rony Seger
Journal:  Biochim Biophys Acta       Date:  2006-10-19

2.  Gene expression analysis in N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice model of Parkinson's disease using cDNA microarray: effect of R-apomorphine.

Authors:  E Grünblatt; S Mandel; G Maor; M B Youdim
Journal:  J Neurochem       Date:  2001-07       Impact factor: 5.372

Review 3.  Molecular pathogenesis of Parkinson's disease.

Authors:  Sonia Gandhi; Nicholas W Wood
Journal:  Hum Mol Genet       Date:  2005-08-26       Impact factor: 6.150

4.  Temporal evolution of mouse striatal gene expression following MPTP injury.

Authors:  R M Miller; L L Chen; G L Kiser; T L Giesler; T M Kaysser-Kranich; C Palaniappan; H J Federoff
Journal:  Neurobiol Aging       Date:  2005-05       Impact factor: 4.673

5.  Quantitative proteome analysis of human plasma following in vivo lipopolysaccharide administration using 16O/18O labeling and the accurate mass and time tag approach.

Authors:  Wei-Jun Qian; Matthew E Monroe; Tao Liu; Jon M Jacobs; Gordon A Anderson; Yufeng Shen; Ronald J Moore; David J Anderson; Rui Zhang; Steve E Calvano; Stephen F Lowry; Wenzhong Xiao; Lyle L Moldawer; Ronald W Davis; Ronald G Tompkins; David G Camp; Richard D Smith
Journal:  Mol Cell Proteomics       Date:  2005-03-07       Impact factor: 5.911

6.  Immunofluorescent labeling of increased calpain expression and neuronal death in the spinal cord of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice.

Authors:  Bhisham Chera; Kurt E Schaecher; Anne Rocchini; Syed Z Imam; Eric A Sribnick; Swapan K Ray; Syed F Ali; Naren L Banik
Journal:  Brain Res       Date:  2004-05-01       Impact factor: 3.252

Review 7.  Current research on methamphetamine-induced neurotoxicity: animal models of monoamine disruption.

Authors:  Taizo Kita; George C Wagner; Toshikatsu Nakashima
Journal:  J Pharmacol Sci       Date:  2003-07       Impact factor: 3.337

8.  Methamphetamine induces neuronal apoptosis via cross-talks between endoplasmic reticulum and mitochondria-dependent death cascades.

Authors:  Subramaniam Jayanthi; Xiaolin Deng; Pierre-Antoine H Noailles; Bruce Ladenheim; Jean Lud Cadet
Journal:  FASEB J       Date:  2004-02       Impact factor: 5.191

9.  A 6-hydroxydopamine-induced selective parkinsonian rat model.

Authors:  D A Perese; J Ulman; J Viola; S E Ewing; K S Bankiewicz
Journal:  Brain Res       Date:  1989-08-14       Impact factor: 3.252

10.  Complex I deficiency primes Bax-dependent neuronal apoptosis through mitochondrial oxidative damage.

Authors:  Celine Perier; Kim Tieu; Christelle Guégan; Casper Caspersen; Vernice Jackson-Lewis; Valerio Carelli; Andrea Martinuzzi; Michio Hirano; Serge Przedborski; Miquel Vila
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-19       Impact factor: 11.205

View more
  37 in total

Review 1.  Rodent models and contemporary molecular techniques: notable feats yet incomplete explanations of Parkinson's disease pathogenesis.

Authors:  Sharawan Yadav; Anubhuti Dixit; Sonal Agrawal; Ashish Singh; Garima Srivastava; Anand Kumar Singh; Pramod Kumar Srivastava; Om Prakash; Mahendra Pratap Singh
Journal:  Mol Neurobiol       Date:  2012-06-27       Impact factor: 5.590

2.  Distinct mechanisms of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrimidine resistance revealed by transcriptome mapping in mouse striatum.

Authors:  R Pattarini; Y Rong; C Qu; J I Morgan
Journal:  Neuroscience       Date:  2008-07-08       Impact factor: 3.590

Review 3.  Role of Mitochondria in Methamphetamine-Induced Dopaminergic Neurotoxicity: Involvement in Oxidative Stress, Neuroinflammation, and Pro-apoptosis-A Review.

Authors:  Eun-Joo Shin; Hai-Quyen Tran; Phuong-Tram Nguyen; Ji Hoon Jeong; Seung-Yeol Nah; Choon-Gon Jang; Toshitaka Nabeshima; Hyoung-Chun Kim
Journal:  Neurochem Res       Date:  2017-06-07       Impact factor: 3.996

4.  A Mutation in Hnrnph1 That Decreases Methamphetamine-Induced Reinforcement, Reward, and Dopamine Release and Increases Synaptosomal hnRNP H and Mitochondrial Proteins.

Authors:  Qiu T Ruan; Neema Yazdani; Benjamin C Blum; Jacob A Beierle; Weiwei Lin; Michal A Coelho; Elissa K Fultz; Aidan F Healy; John R Shahin; Amarpreet K Kandola; Kimberly P Luttik; Karen Zheng; Nathaniel J Smith; Justin Cheung; Farzad Mortazavi; Daniel J Apicco; Durairaj Ragu Varman; Sammanda Ramamoorthy; Peter E A Ash; Douglas L Rosene; Andrew Emili; Benjamin Wolozin; Karen K Szumlinski; Camron D Bryant
Journal:  J Neurosci       Date:  2019-11-08       Impact factor: 6.167

5.  Integrated analysis of proteome and transcriptome changes in the mucopolysaccharidosis type VII mouse hippocampus.

Authors:  Michael K Parente; Ramona Rozen; Steven H Seeholzer; John H Wolfe
Journal:  Mol Genet Metab       Date:  2016-03-07       Impact factor: 4.797

Review 6.  New insight into neurodegeneration: the role of proteomics.

Authors:  Ramavati Pal; Guido Alves; Jan Petter Larsen; Simon Geir Møller
Journal:  Mol Neurobiol       Date:  2013-12-10       Impact factor: 5.590

Review 7.  Mitochondrial dysfunction in mouse models of Parkinson's disease revealed by transcriptomics and proteomics.

Authors:  Desmond J Smith
Journal:  J Bioenerg Biomembr       Date:  2009-12       Impact factor: 2.945

Review 8.  Mitochondrial respiratory complex I: structure, function and implication in human diseases.

Authors:  Lokendra K Sharma; Jianxin Lu; Yidong Bai
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

Review 9.  Target identification for CNS diseases by transcriptional profiling.

Authors:  C Anthony Altar; Marquis P Vawter; Stephen D Ginsberg
Journal:  Neuropsychopharmacology       Date:  2008-10-15       Impact factor: 7.853

10.  Network and Pathway-Based Analyses of Genes Associated with Parkinson's Disease.

Authors:  Yanshi Hu; Zhenhua Pan; Ying Hu; Lei Zhang; Ju Wang
Journal:  Mol Neurobiol       Date:  2016-06-27       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.